TrialPath
Recruiting

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

NCT04946916 · Hôpital le Vinatier
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases
About this study
One hundred twenty participants will be included in this study * 30 participants suffering from psychiatric disorders (bipolar disorder or schizophrenia) without cognitive impairment * 30 participants suffering from psychiatric disorders (bipolar disorder or schizophrenia) with cognitive impairment * 30 participants with a biological diagnosis of Alzheimer's disease * 30 participants with frontotemporal dementia according to Rascosky's criteria All the participants will perform cognitive, behavioral, and psychiatric evaluation and will be have blood sample taken.
Eligibility criteria
Inclusion Criteria: * haven given written consent Participants with psychiatric conditions: * Schizophrenia (DSM-V criteria) with or without cognitive involution * Bipolar disorder (DSM-V criteria) with or without cognitive involution Participants with neurodegenerative disease: * probable or definite FTD (Rascovsky criteria 2011) * Biological Alzheimer's disease with typical CSF (NIA-AA 2011) Exclusion Criteria: * Uninterviewable patient and/or missing history * History of recent or previous head trauma with loss of consciousness * History of ischemic or hemorrhagic stroke * Chronic alcoholism / chronic drug use * Progressive somatic pathology / severe metabolic disorder / poorly controlled epilepsy * Age \< 45 years * Age \> 80 years * Electroconvulsive therapy for less than 6 months
Study design
Enrollment target: 120 participants
Allocation: non_randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2021-10-22
Estimated completion: 2028-03-22
Last updated: 2025-07-24
Interventions
Diagnostic Test: blood sample taken
Primary outcomes
  • • neurofilament light chain (two months)
Sponsor
Hôpital le Vinatier · other
Contacts & investigators
ContactDorey Jean-Michel, MD,PHD · contact · jean-michel.dorey@ch-le-vinatier.fr · 0437915249
ContactSARTELET lydie · contact · lydie.sartelet@ch-le-vinatier.fr · 0437915531
InvestigatorJean-Michel DOREY, MD, PHD · principal_investigator, CH le Vinatier
All locations (2)
HCL Consultation mémoire Neurologique -Hôpital NeurologiqueRecruiting
Bron, France
Centre Hospitalier Le VinatierRecruiting
Bron, France
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease · TrialPath